- Home
- DHIL vs NGNE Comparison
DHIL vs NGNE Comparison
Compare DHIL & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHIL
- NGNE
- Stock Information
- Founded
- DHIL 1990
- NGNE 2003
- Country
- DHIL United States
- NGNE United States
- Employees
- DHIL N/A
- NGNE N/A
- Industry
- DHIL Investment Managers
- NGNE Biotechnology: Pharmaceutical Preparations
- Sector
- DHIL Finance
- NGNE Health Care
- Exchange
- DHIL Nasdaq
- NGNE Nasdaq
- Market Cap
- DHIL 424.8M
- NGNE 471.1M
- IPO Year
- DHIL 1995
- NGNE N/A
- Fundamental
- Price
- DHIL $169.65
- NGNE $15.59
- Analyst Decision
- DHIL
- NGNE Strong Buy
- Analyst Count
- DHIL 0
- NGNE 6
- Target Price
- DHIL N/A
- NGNE $60.80
- AVG Volume (30 Days)
- DHIL 14.3K
- NGNE 539.5K
- Earning Date
- DHIL 11-04-2024
- NGNE 11-18-2024
- Dividend Yield
- DHIL 3.53%
- NGNE N/A
- EPS Growth
- DHIL 21.33
- NGNE N/A
- EPS
- DHIL 17.67
- NGNE N/A
- Revenue
- DHIL $145,795,446.00
- NGNE $925,000.00
- Revenue This Year
- DHIL N/A
- NGNE N/A
- Revenue Next Year
- DHIL N/A
- NGNE N/A
- P/E Ratio
- DHIL $9.60
- NGNE N/A
- Revenue Growth
- DHIL 5.76
- NGNE N/A
- 52 Week Low
- DHIL $135.44
- NGNE $12.49
- 52 Week High
- DHIL $173.98
- NGNE $74.49
- Technical
- Relative Strength Index (RSI)
- DHIL 61.47
- NGNE 26.51
- Support Level
- DHIL $167.89
- NGNE $35.60
- Resistance Level
- DHIL $171.70
- NGNE $43.24
- Average True Range (ATR)
- DHIL 2.72
- NGNE 6.30
- MACD
- DHIL 0.51
- NGNE -5.15
- Stochastic Oscillator
- DHIL 83.79
- NGNE 1.85
About DHIL Diamond Hill Investment Group Inc.
Diamond Hill Investment Group Inc sponsors, markets, and provides investment advisory and related services to various U.S. and foreign clients including mutual funds, separate accounts, and private investment funds. The company's objective is to fulfill a fiduciary duty to clients and secondary objectives to achieve an adequate long-term return for shareholders. The company generates its revenue from Investment advisory and fund administration fees.
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.